Monthly Archives: June 2015

MLV & Co. Believes SRNE Won’t Stop Here

MLV & Co. analyst Ram Selvaraju maintained a Buy rating on Sorrento Therapeutics (NASDAQ: SRNE) today and set a price target of $33. The company’s shares opened today at $17.62, close to its 52-week high of $17.80. Selvaraju wrote, “Yesterday,

Ring Energy Receives a Buy from Roth Capital

Roth Capital analyst John M. White reiterated a Buy rating on Ring Energy (NYSE: REI) today and set a price target of $18.50. The company’s shares opened today at $11.19. White said, “significant uplift in proved reserves, CFPS and EBITDA.

Power Solutions Receives a Buy from Roth Capital

Roth Capital analyst Craig Irwin maintained a Buy rating on Power Solutions (NASDAQ: PSIX) today and set a price target of $90. The company’s shares opened today at $54.02. Power Solutions has an analyst consensus of Strong Buy. Power Solutions`

MLV & Co. Maintains a Buy Rating on Oramed Pharmaceuticals

In a report released today, Ram Selvaraju from MLV & Co. maintained a Buy rating on Oramed Pharmaceuticals (NASDAQ: ORMP), with a price target of $30. The company’s shares opened today at $5.68. Selvaraju wrote, “This morning, Oramed reported that

Lion Biotechnologies Receives a Buy from Roth Capital

Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Lion Biotechnologies (OTHEROTC: LBIO) today and set a price target of $17. The company’s shares opened today at $9.17. Pantginis commented, “We believe Celgene’s (CELG-NC) ~$1 billion investment into Juno

Egalet Corp Receives a Buy from Canaccord Genuity

Canaccord Genuity analyst John Newman maintained a Buy rating on Egalet Corp (NASDAQ: EGLT) today and set a price target of $25. The company’s shares opened today at $14.43. Currently, the analyst consensus on Egalet Corp is Strong Buy and